Ra Capital Management as of June 30, 2023
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 54 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 18.9 | $1.0B | 11M | 89.25 | |
| Legend Biotech 2 Adr Rep Ord (LEGN) | 8.2 | $433M | 6.3M | 69.03 | |
| Vaxcyte Sponsored Ads (PCVX) | 7.4 | $394M | 7.9M | 49.94 | |
| Dice Therapeutics | 6.9 | $365M | 7.9M | 46.46 | |
| 89bio (ETNB) | 4.1 | $216M | 11M | 18.95 | |
| Biogen Sponsored Adr (BIIB) | 2.9 | $152M | 533k | 284.85 | |
| Aerovate Therapeutics (AVTE) | 2.7 | $142M | 8.3M | 17.15 | |
| Verona Pharma Plc ads (VRNA) | 2.5 | $134M | 6.3M | 21.14 | |
| Curevac N V (CVAC) | 2.4 | $128M | 12M | 10.42 | |
| Tyra Biosciences (TYRA) | 2.3 | $123M | 7.2M | 17.03 | |
| Newamsterdam Pharma Company Ord Shs (NAMS) | 2.0 | $107M | 9.0M | 11.89 | |
| Cytek Biosciences (CTKB) | 2.0 | $105M | 12M | 8.54 | |
| Janux Therapeutics (JANX) | 1.9 | $103M | 8.7M | 11.87 | |
| Geron Corporation (GERN) | 1.9 | $101M | 32M | 3.21 | |
| Inhibrx SHS (INBX) | 1.9 | $100M | 3.9M | 25.96 | |
| Rhythm Pharmaceuticals (RYTM) | 1.8 | $94M | 5.7M | 16.49 | |
| Day One Biopharmaceuticals I (DAWN) | 1.8 | $93M | 7.8M | 11.94 | |
| Rxsight (RXST) | 1.7 | $88M | 3.1M | 28.80 | |
| Cogent Biosciences (COGT) | 1.4 | $76M | 6.4M | 11.84 | |
| Pepgen (PEPG) | 1.4 | $73M | 8.1M | 8.94 | |
| Axsome Therapeutics Class A Ord Shs (AXSM) | 1.4 | $72M | 1.0M | 71.86 | |
| Avidity Biosciences Ord (RNA) | 1.3 | $71M | 6.4M | 11.09 | |
| Vor Biopharma (VOR) | 1.3 | $70M | 23M | 3.09 | |
| Gh Research Sponsored Adr (GHRS) | 1.3 | $66M | 5.6M | 11.87 | |
| Wave Life Sciences (WVE) | 1.2 | $63M | 17M | 3.64 | |
| Acrivon Therapeutics (ACRV) | 1.2 | $62M | 4.8M | 12.96 | |
| Icosavax | 1.1 | $59M | 6.0M | 9.93 | |
| Iteos Therapeutics (ITOS) | 1.1 | $59M | 4.4M | 13.24 | |
| 4d Molecular Therapeutics In (FDMT) | 1.0 | $56M | 3.1M | 18.07 | |
| Mineralys Therapeutics (MLYS) | 1.0 | $54M | 3.2M | 17.05 | |
| Alpine Immune Sciences (ALPN) | 0.9 | $48M | 4.7M | 10.28 | |
| Miragen Therapeutics (VRDN) | 0.9 | $48M | 2.0M | 23.79 | |
| Acumen Pharmaceuticals Common Stock (ABOS) | 0.9 | $47M | 9.8M | 4.81 | |
| Aclaris Therapeutics Sponsored Ads (ACRS) | 0.9 | $46M | 4.4M | 10.37 | |
| ImmunoGen | 0.8 | $44M | 2.3M | 18.87 | |
| Enliven Therapeutics (ELVN) | 0.8 | $43M | 2.1M | 20.41 | |
| Fulcrum Therapeutics Class A Com (FULC) | 0.7 | $38M | 12M | 3.30 | |
| Eliem Therapeutics Ads (ELYM) | 0.7 | $37M | 13M | 2.80 | |
| Tenaya Therapeutics (TNYA) | 0.7 | $36M | 6.1M | 5.87 | |
| An2 Therapeutics (ANTX) | 0.6 | $32M | 3.8M | 8.50 | |
| Pliant Therapeutics (PLRX) | 0.6 | $32M | 1.8M | 18.12 | |
| Eyepoint Pharmaceuticals (EYPT) | 0.6 | $29M | 3.4M | 8.70 | |
| Silverback Therapeutics (SPRY) | 0.4 | $20M | 3.0M | 6.70 | |
| Werewolf Therapeutics (HOWL) | 0.4 | $19M | 6.1M | 3.05 | |
| Design Therapeutics (DSGN) | 0.4 | $19M | 3.0M | 6.30 | |
| Solid Biosciences (SLDB) | 0.3 | $18M | 3.4M | 5.24 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $18M | 3.5M | 5.05 | |
| Nkarta (NKTX) | 0.3 | $17M | 7.8M | 2.19 | |
| Celcuity (CELC) | 0.3 | $15M | 1.4M | 10.98 | |
| Igm Biosciences (IGMS) | 0.2 | $8.7M | 938k | 9.23 | |
| Connect Biopharma Hldgs (CNTB) | 0.1 | $7.9M | 7.0M | 1.13 | |
| Talaris Therapeutics | 0.1 | $7.1M | 2.3M | 3.04 | |
| Nanostring Technologies Ordinary Shares (NSTGQ) | 0.1 | $7.0M | 1.7M | 4.05 | |
| Newamsterdam Pharma Company Ord Shs (NAMSW) | 0.0 | $697k | 333k | 2.09 |
